Wedbush Initiates Coverage On CG Oncology with Outperform Rating, Announces Price Target of $70
Benzinga Newsdesk 11 months ago
NewsPrice TargetInitiationAnalyst Ratings
Wedbush analyst Robert Driscoll initiates coverage on CG Oncology (NASDAQ:CGON) with a Outperform rating and announces Price Target of $70.
Wedbush analyst Robert Driscoll initiates coverage on CG Oncology (NASDAQ:CGON) with a Outperform rating and announces Price Target of $70.